Company News
Aurobindo Pharma USA Receives FTC Approval for Lannett Acquisition
Aurobindo Pharma USA receives FTC approval for $250 million acquisition of Lannett Company LLC.
Acquisition adds 4 billion dose annual manufacturing capacity and complex generic pharmaceuticals portfo